Symposiums

Dr Queiro-Silva opened the session by proposing a definition of the moderate-severity PsA patient: patients associated with a limited number of affected…

The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a group of rare inflammatory diseases including microscopic polyangiitis…

Prof Elke de Jong focussed her presentation on data from randomised clinical trials (RCT) and real-world evidence (RWE) from psoriasis patient registries.

Dermatologists frequently see psoriasis patients for whom the most troublesome symptoms are not the constant physical discomfort…

Migraine is a complex neurological disorder with an approximate global prevalence of 15%. It is characterised by a moderate-to-severe unilateral…

Treatment of MM requires a multifaceted approach using a combination of therapies targeting the several pathophysiological pathways involved in the…

Haemodialysis was developed to alleviate symptoms due to accumulating uraemic toxins and acute fluid overload in patients with advancing chronic kidney…

Anti-TNF biologics have revolutionised treatment of RA. More recently, the emergence of high-quality biosimilars has provided a cost-effective means of…